about
Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignanciesHow we treat chronic graft-versus-host disease.Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans.Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host DiseaseAllogeneic hematopoietic cell transplantation for MDS: for whom, when and how?A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.Extracorporeal photopheresis in the management of graft-versus-host disease.Extracorporeal photopheresis: clinical use so far.Long-term follow-up of informal caregivers after allo-SCT: a systematic review.Extracorporeal photopheresis after heart transplantation.Therapeutic apheresis for patients with cancer.Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells.Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD.Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI).Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease.National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
P2860
Q33795160-BC4939C1-F1BF-4650-90D1-B814787C15B4Q35004923-CD85F4F0-40F1-4FB9-913D-EEAE60A5119FQ35140097-F9C51370-01A8-4E4A-8AA9-46A4DA3DFED0Q35607308-C242DA4A-4648-4CB3-A63E-879F82CDBD0EQ35692054-5FCFCF7A-7D01-4CE6-9F26-647D57C323F3Q36285222-6F779E7E-BEFA-4B26-AD54-30794964C943Q36431041-B81E5E39-4294-49C7-9C7E-207D19519F8BQ36471247-E9A12A0B-5C29-49AC-93DD-4D1AE8B5C807Q36709850-103D90E7-350C-4FED-A6F1-424F7323DD67Q36813127-76C8676A-410C-4545-A513-ADC0E3DEA9D7Q37719634-D4EC859B-9DDB-47C0-BF11-2243A79147E6Q37998968-80F32D31-AE83-4C22-8551-7CA7E27D3878Q38021619-48313DDC-87E1-4997-89F2-E09C56417DD4Q38260052-41AFC238-0C3A-4A18-BA24-892B438E05B0Q38287610-587A226C-5158-4BC6-A402-A38385597067Q38392246-4245FB5A-FD1E-4289-8E69-EB0E7F5D682CQ39002164-AE0A582E-DE99-461E-8072-AE255808CC72Q42360160-77938919-C1B7-4E38-A21F-9F84E2D5E62EQ43413019-4861C653-AEE6-417C-B6AF-B29F7947DC84Q45866879-004DB9FB-3770-4274-8D22-6C2EE530DACAQ46136248-D4193E0D-25A2-4C47-8289-DCF80E28DC61Q46428638-C89A6492-7E17-4E2E-A2F0-23CB28F576E7Q48258672-8CC7C548-4385-40AC-961B-95ACD9A6245BQ49630800-14750F7A-7067-419F-926F-C6FA44E40A42Q50861552-AB4F14F3-F00F-4D91-8D2E-BC67C84C25B1
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment of chronic graft-versus-host disease in 2011
@ast
Treatment of chronic graft-versus-host disease in 2011
@en
Treatment of chronic graft-versus-host disease in 2011
@nl
type
label
Treatment of chronic graft-versus-host disease in 2011
@ast
Treatment of chronic graft-versus-host disease in 2011
@en
Treatment of chronic graft-versus-host disease in 2011
@nl
prefLabel
Treatment of chronic graft-versus-host disease in 2011
@ast
Treatment of chronic graft-versus-host disease in 2011
@en
Treatment of chronic graft-versus-host disease in 2011
@nl
P2860
P1476
Treatment of chronic graft-versus-host disease in 2011
@en
P2093
Mary E.D. Flowers
Yoshihiro Inamoto
P2860
P304
P356
10.1097/MOH.0B013E32834BA87D
P407
P577
2011-11-01T00:00:00Z